Role of microparticles in sepsis

British Journal of Anaesthesia

Volumn 109, Issue 4, 2012, Pages 503-513

  Reid, V L ^a   Webster, N R ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Coagulation; Endothelial dysfunction; Inflammation; Microparticles; Sepsis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR; MEMBRANE ANTIGEN; PHOSPHATIDYLSERINE; THROMBOPLASTIN;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANGIOGENESIS; ANTICOAGULATION; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL ADHESION; CELL DESTRUCTION; CELL PROLIFERATION; CELL STIMULATION; CHEMOTAXIS; CYTOKINE RELEASE; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ERYTHROCYTE; HEMOSTASIS; INFLAMMATION; LYMPHOCYTE; MEMBRANE MICROPARTICLE; MEMBRANE VESICLE; MONOCYTE; NEUTROPHIL; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; THROMBOCYTE; THROMBOSIS;

EID: 84866393115     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes321     Document Type: Review

References (103)

1. Chargaff E, West R. The biological significance of the thromboplastin protein of blood. J Biol Chem 1946; 166: 189-97
2. Zachowski A. Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J 1993; 294: 1-14 (Pubitemid 23251903)
3. Devaux PF. Lipid transmembrane asymmetry and flip-flop in biological membranes and in lipid bilayers. Curr Opin Struct Biol 1993; 3: 489-94 (Pubitemid 23261398)
4. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967; 13: 269-88
5. Combes V, Simon AC, Grau GE, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102 (Pubitemid 29534349)
6. Brisset AC, Terrisse AD, Dupouy D, et al. Shedding of active tissue factor by aortic smooth muscle cells (SMCs) undergoing apoptosis. Thromb Haemost 2003; 90: 511-8 (Pubitemid 37138777)
7. Allan D, Thomas P, Limbrick AR. The isolation and characterisation of 60 nm vesicles ('nanovesicles') produced during ionophore A23187-induced budding of human erythrocytes. Biochem J 1980; 188: 881-7 (Pubitemid 10023637)
8. Hess C, Sadallah S, Hefti A, Landmann R, Schifferli JA. Ectosomes released by human neutrophils are specialised functional units. J Immunol 1999; 163: 4564-73 (Pubitemid 29474527)
9. Gasser O, Hess C, Miot S, Deon C, Sanchez JC, Schifferli JA. Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res 2003; 285: 243-57 (Pubitemid 36432112)
10. Aupeix K, Hgel B, Martin T, et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 1997; 99: 1546-54 (Pubitemid 27163805)
11. Satta N, Toti F, Feugeas O, et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharides. J Immunol 1994; 153: 3245-55 (Pubitemid 24292551)
12. Burnier L, Fontana P, Brenda R, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009; 101: 439-51
13. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular disease. Cardiovasc Res 2003; 59: 277-87
14. Piccin A, Murphy W, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-71 (Pubitemid 46529055)
15. Flaumenhaft R, Dilks JR, Richardson J, et al. Platelets and thrombopoiesis megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 2009; 113: 1112-21
16. George JN, Thoi LL, McManus LM, Reimann TA. Isolation of human platelet membrane microparticles from plasma and serum. Blood 1982; 60: 834-40 (Pubitemid 12001441)
17. Holme PA, Solum NO, Brosstad F, Roøger M, Abdelnoor M. Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting. Thromb Haemost 1994; 72: 666-71 (Pubitemid 24341039)
18. Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004; 9: 1118-35 (Pubitemid 39060833)
19. Chou J, Mackmann N, Merrill-Skoloff G, Pedersen B, Furie BC, Furie B. Haematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004; 104: 3190-7 (Pubitemid 39507134)
20. Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95: 930-5 (Pubitemid 30063043)
21. Ogura H, Kawasaka T, Tamaka H, et al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma 2001; 50: 801-9 (Pubitemid 32499602)
22. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991; 77: 2641-8
23. Siljander P, Carpen O, Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood 1996; 87: 4651-63 (Pubitemid 26162364)
24. Barry OP, Kazanietz MG, PraticóD, FitzGerald GA. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2- dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 1999; 274: 7545-56
25. Barry OP, PraticóD, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997; 99: 2118-27 (Pubitemid 27203768)
26. Barry OP, PraticóD, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136-44 (Pubitemid 28323840)
27. Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol 1998; 161: 4382-7 (Pubitemid 28469024)
28. Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signalling pathway. J Biol Chem 1999; 274: 23111-8
29. Forlow S, McEver RP, Nollert MU. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000; 95: 1317-23 (Pubitemid 30099841)
30. Jy W, Mao WW, Horstman LL, Tao J, Ahn YS. Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 1995; 21: 217-31 (Pubitemid 26083518)
31. Cerri C, Chimenti D, Conti I, Neri T, Paggiaro P, Celi A. Monocyte/macrophage-derived microparticles up-regulate inflammatory mediator synthesis by human airway epithelial cells. J Immunol 2006; 177: 1975-80 (Pubitemid 44092538)
32. Bardelli C, Amoruso A, Federici Canova D, et al. Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation of PPARg ligands. Br J Pharmacol 2012; 165: 716-28
33. Berckmans RJ, Nieuwland R, Böing AN, Romijn F, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639-46 (Pubitemid 32293699)
34. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 17049-57 (Pubitemid 19255533)
35. Meziani F, Tesse A, Andriantsitohaina R. Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases. Pharmacol Rep 2008; 60: 75-84 (Pubitemid 351586545)
36. Holme PA, Solum NO, Brosstad F, Pedersen T, Kveine M. Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets. Thromb Haemost 1998; 79: 389-94 (Pubitemid 28065890)
37. Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991; 266: 17261-8 (Pubitemid 21907934)
38. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, et al. Cellderived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997; 96: 3534-41 (Pubitemid 27513430)
39. Iwamoto S, Kawasaki T, Kambayashi J, Ariyoshi H, Monden M. Platelet microparticles: a carrier of platelet-activating factor? Biochem Biophys Res Commun 1996; 218: 940-4 (Pubitemid 26050767)
40. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Soderland C, Ahn YS. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol 2003; 123: 896-902 (Pubitemid 37533302)
41. Jy W, Jimenez JJ, Mauro LM, et al. Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. J Thromb Haemost 2005; 3: 1301-8 (Pubitemid 41725256)
42. Hamilton KK, Hattori R, Esmon CT, Sims PJ. Complement proteins C5b-9 induced vesiculation of the endothelial plasma membrane and expose catalytic surface assembly of the prothrombinase enzyme complex. J Biol Chem 1990; 265: 3809-14
43. Brodsky SV, Malinowski K, Golightly M, Jesty J, Goligorsky MS. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation 2002; 106: 2372-8 (Pubitemid 35244740)
44. Combes V. Circulating endothelial microparticles in Malawian children with severe falciparum malaria complicated with coma. J Am Med Assoc 2004; 291: 2542-3
45. Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle Pselectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-98 (Pubitemid 36682554)
46. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE. Mechanisms underlying coagulation abnormalities in Ebola haemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 2003; 188: 1618-29 (Pubitemid 38010671)
47. Boulanger CM, Scoazec A, Ebrahimian T, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104: 2649-52 (Pubitemid 33108128)
48. Mallat Z, Hugel B, Ohan J, et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role of apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-53 (Pubitemid 29051259)
49. VanWijk MJ, Svedas E, Boer K, Nieuwland R, VanBavel E, Kublickiene KR. Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelial-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol 2002; 187: 1686-93 (Pubitemid 36026708)
50. Meziani F, Tesse A, David E, et al. Shed membrane particles from pre-eclamptic women generate vascular wall inflammation and blunt vascular contractility. Am J Pathol 2006; 169: 1473-83 (Pubitemid 351194378)
51. Amabile N, Guérin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16: 3381-8 (Pubitemid 46179341)
52. Tesse A, Meziani F, David E, et al. Microparticles from preeclamptic women induce vascular hyporeactivity in vessels from pregnant mice through overproduction of NO. Am J Physiol Heart Circ Physiol 2007; 293: H520-5 (Pubitemid 47105111)
53. Aharon A, Brenner B. Microparticles and pregnancy complications. Thromb Res 2011; 127: S67-71
54. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS. Endotheliumderived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 2004; 286: H190-5
55. Martin S, Tesse A, Hugel B, et al. Shed microparticles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation 2004; 109: 1653-9 (Pubitemid 38451723)
56. Tesse A, Martínez C, Hugel B, et al. Upregulation of proinflammatory proteins through NF-kB pathway by shed membrane microparticles results in vascular hyporeactivity. Arterioscler Thromb Vasc Biol 2005; 25: 2522-7 (Pubitemid 43732273)
57. Werner N,Wassmann S, Ahlers P, Kosiol S, Nickenig G. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 120: 112-6 (Pubitemid 43732236)
58. Amabile N, Boulanger CM. Circulating microparticle levels in patients with coronary artery disease: a new indicator of vulnerability? Eur Heart J 2011; 32: 1958-60
59. Sinning JM, Losch J, Walenta K, Bohm M, Nickenig G, Werner N. Circulating CD31+/annexin V+ apoptotic microparticles correlate with cardiovascular outcomes. Eur Heart J 2011; 32: 2034-41
60. Nozaki T, Sugiyama S, Koga H, et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cadiol 2009; 54: 601-8
61. Amabile N, Boulanger CM, Guerin A, Tedgui A, London G. Circulating endothelial microparticles: a novel biomarker for cardiovascular death and cardiovascular events in end-stage-renal disease. Circulation 2009; 120: S1010
62. Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011; 31: 27-33
63. Kim HK, Song KS, Chung JH, Lee KR, Lee SN. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004; 124: 376-84 (Pubitemid 38167990)
64. Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D. Platelet-derived microparticles induce angiogenesis and stimulate postischaemic revascularisation. Cardiovasc Res 2005; 67: 30-8 (Pubitemid 40798290)
65. Leroyer AS, Rautou PE, Silvestre JS. CD4 ligand+microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis. J Am Coll Cardiol 2008; 52: 1302-11
66. Amabile N, Rautou PE, Tedgui A, Boulanger CM. Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Haemost 2010; 36: 907-16
67. Tarabolletti G, D'Ascenzo S, Borsotti P, Gaivazzi R, Pavan A, Dolo V. Shedding of matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 2002; 160: 673-80 (Pubitemid 34160345)
68. Gasser O, Schifferli JA. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 2004; 104: 2543-8 (Pubitemid 39331859)
69. Dalli J, Norling LV, Renshaw D, Cooper D, Leung KY, Perretti M. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. Blood 2008; 112: 2512-9
70. Pérez-Casal M, Downey C, Fukudome K, Marx G, Toh CH. Activated protein C induces the release of microparticle-associated endothelial protein C receptor. Blood 2005; 105: 1515-22 (Pubitemid 40223668)
71. Diehl JL, Borgel D. Sepsis and coagulation. Curr Opin Crit Care 2005; 11: 454-60 (Pubitemid 41482701)
72. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365: 63-78
73. Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008; 83: 536-45 (Pubitemid 351966862)
74. Salvemini D, Cuzzocrea S. Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med 2002; 33: 1173-85 (Pubitemid 35246585)
75. Peters K, Unger RE, Brunner J, Kirkpatrick CJ. Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 2003; 60: 49-57 (Pubitemid 38373475)
76. Clapp BR, Hingorani AD, Kharbanda RK, et al. Inflammationinduced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidative stress. Cardiovasc Res 2004; 64: 172-8 (Pubitemid 39208934)
77. van der Poll T. Tissue factor as an initiator of coagulation and inflammation in the lung. Crit Care 2008; 12: S3
78. Guervilly C, Lacroix R, Forel JM. High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome. Crit Care 2011; 15: R31
79. Brown GT, McIntyre TM. Liopopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1b-rich microparticles. J Immunol 2011; 186: 5489-96
80. Aras O, Shet A, Bach RR, et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004; 103: 4545-53 (Pubitemid 38745982)
81. Itakura Y, Ogura H, Tanaka H, et al. Paradoxical cytoskeleton and microparticle formation chances in monocytes and polymorphonuclear leukocytes in severe systemic inflammatory response syndrome patients. J Trauma 2003; 55: 1125-32 (Pubitemid 38044130)
82. Fujimi S, Ogura H, Tanaka H, et al. Activated polymorphonuclear leukocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis. J Trauma 2002; 52: 443-8 (Pubitemid 34230072)
83. Ogura H, Tanaka H, Koh T, et al. Enhanced production of endothelial microparticles with increased binding to leukocytes in patients with severe systemic inflammatory response syndrome. J Trauma 2004; 56: 823-31
84. Janiszewski M, do Carmo AO, Pedro MA, Silva E, Knobel E, Laurindo FRM. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: a novel vascular redox pathway. Crit Care Med 2004; 32: 818-25 (Pubitemid 38340083)
85. Gambin MH, do Carmo AO, Marti L, Veríssimo-Filho S, Lopes LR, Janiszewski M. Platelet-derived exosomes induced endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction. Crit Care 2007; 11: R107
86. Mortaza S, Martinez C, Baron-Menguy C, et al. Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats. Crit Care Med 2009; 37: 2045-50
87. Mostefai HA, Meziani F, Mastronardi ML, et al. Circulating microparticles from patients with septic shock exert protective role in vascular function. Am J Respir Crit Care Med 2008; 178: 1148-55
88. Laher I. Microparticles have a macro effect in sepsis. Crit Care Med 2011; 39: 1842-3
89. Bastarache JA, Fremont RD, Kropski JA, Bossert FR, Ware LB. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1035-41
90. Densmore JC, Signorino PR, Jingsong O, et al. Endotheliumderived microparticles induce endothelial dysnfunction and acute lung injury. Shock 2006; 26: 464-71 (Pubitemid 44632275)
91. Lew TW, Kwek TK, Tai D. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. J Am Med Assoc 2003; 290: 374-80 (Pubitemid 37430524)
92. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995; 108: 1303-14
93. Morel N, Morel O, Petit L, et al. Generation of procoagulant microparticles in cerebrospinal fluid and peripheral blood after traumatic brain injury. J Trauma 2008; 64: 698-704 (Pubitemid 351366895)
94. Forest A, Pautas E, Ray P, et al. Circulating microparticles and procoagulant activity in elderly patients. J Gerontol A Biol Sci Med Sci 2010; 65A: 414-20
95. Mastronardi ML, Mostefai HA, Meziani F, Martínez MC, Asfar P, Andriantsitohaina R. Circulating microparticles from septic shock patients exert differential tissue expression of enzymes related to inflammation and oxidative stress. Crit Care Med 2011; 39: 1739-48
96. Soriano AO, Jy W, Chirinos JA, et al. Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Crit Care Med 2005; 33: 2540-6 (Pubitemid 41682106)
97. Morel O, Toti F, Morel N, Freyssinet JM. Microparticles in endothelial cell and vascular homeostasis: are they really noxious? Haematologica 2009; 94: 313-7
98. Jy W, Horstman LL, Jimenez JJ, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842-51 (Pubitemid 40197488)
99. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006; 48: 180-8
100. Mack M, Kleinschmidt A, Bruhl H, et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 2000; 6: 769-75 (Pubitemid 30469425)
101. Huber J, Vales A, Mitulovic G, et al. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte- endothelial interactions. Art Thromb Vasc Biol 2002; 22: 101-7 (Pubitemid 34076239)
102. Patel KD, Zimmerman GA, Prescott SM, McIntyre TM. Novel leukocyte agonists are released by endothelial cells exposed to peroxide. J Biol Chem 1992; 267: 15168-75
103. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106: 1604-11 (Pubitemid 41208572)